logo
Barriers to maternity care in rural Kansas leave many moms-to-be miles from services

Barriers to maternity care in rural Kansas leave many moms-to-be miles from services

Yahoo16-05-2025

A graphic from a report on maternity care deserts shows the number of facilities offering inpatient obstetrics care across the state of Kansas. (United Methodist Health Ministry Fund/KU School of Nursing)
TOPEKA — Maternity care is becoming out of reach for many in rural Kansas counties, where birth rates are higher than in urban areas, hospitals face closure and obstetrics services are few and far between.
The new report from the University of Kansas School of Nursing and Hutchinson-based United Methodist Health Ministry Fund examined Kansas' maternity care deserts, or counties without nearby access to prenatal and obstetrics care.
The findings 'paint a stark picture of the current landscape of access to maternal health,' said David Jordan, president and CEO of the health fund, which commissioned and funded the report. The report was based on statewide data from 2022-2024.
'The data also emphasize the critical importance of addressing this challenge before it gets worse, as well as recognizing that the location of services is one piece of the puzzle,' he said.
More than 40% of Kansas counties don't have any maternal care services, and most Kansans live 30 miles or more from a high-risk delivery facility, the report found. Plus, most rural counties in the state do not have an obstetrician/gynecologist.
In western Kansas, Grant and Wallace counties, which sit on or near the Kansas-Colorado border, have the highest birth rates in the state. Wallace County, home to roughly 1,700 people, has no hospitals, birthing centers or facilities offering prenatal services. The closest facility offering inpatient maternity care is at least 50 miles away. In Grant County, maternity care isn't available at existing facilities, the report found, and the closest maternity care facility is at least 24 miles away.
Labor and delivery services and high-risk care are most difficult to access, the report found. About 30% of Kansas ZIP codes are 100 miles or more from high-risk pregnancy services.
Medicaid, the joint federal and state public health insurance program, pays for about 40% of all births in Kansas. After delivery, mothers are eligible for continued coverage for a year if they make an annual income less than or equal to 171% of the federal poverty level, which amounts to $47,453 or less for a family of four.
The report also revealed the unrecognized costs associated with providing maternity care, which requires the constant presence and attention of teams of nurses and clinicians. Reimbursement rates through public insurance programs can be lacking.
Addressing maternal care deserts requires sound data, said Karen Weis, the lead author of the report and dean of KU School of Nursing-Salina.
'Kansas legislators, health care systems, foundations, professional organizations and educational institutions are all working hard to address the concerns of access to care and the health care workforce,' she said.
The report highlight four priorities to improve the state's maternal health care. Providers could use telehealth more frequently as a way to expand maternal health options. Rural areas could create regional models of care so providers can more easily collaborate.
The Legislature could increase reimbursement rates for maternity care services to ease affordability concerns and retain care providers.
'Eighty-six percent of Kansas hospitals experienced a loss of services in 2023, 63% are at risk of closing and 32% are at risk of immediate closure,' the report said.
The report encouraged further engagement and research to maximize scarce resources.
Jordan said Kansas needs new, innovative solutions 'to complete the puzzle in order to provide women, children and families across the state with better access to the services they need to thrive.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI
AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI

Business Insider

time7 hours ago

  • Business Insider

AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI

Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca's (AZN) IMFINZI in combination with standard-of-care FLOT chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of event-free survival, EFS, versus chemotherapy alone. Patients were treated with neoadjuvant IMFINZI in combination with chemotherapy before surgery, followed by adjuvant IMFINZI in combination with chemotherapy, then IMFINZI monotherapy. The trial evaluated this regimen versus perioperative chemotherapy alone for patients with resectable, early-stage and locally advanced gastric and gastroesophageal junction, GEJ, cancers. In a planned interim analysis, patients treated with the IMFINZI-based perioperative regimen showed a 29% reduction in the risk of disease progression, recurrence or death versus chemotherapy alone. Estimated median EFS was not yet reached for the IMFINZI arm versus 32.8 months for the comparator arm. For the secondary endpoint of overall survival, a strong trend was observed in favor of the IMFINZI-based perioperative regimen. The trial will continue to follow OS, which will be formally assessed at the final analysis. Confident Investing Starts Here:

Guardant Health presented results of largest study on ctDNA in colon cancer
Guardant Health presented results of largest study on ctDNA in colon cancer

Business Insider

time7 hours ago

  • Business Insider

Guardant Health presented results of largest study on ctDNA in colon cancer

Guardant Health (GH) presented results of the largest study to date evaluating circulating tumor DNA, ctDNA, in colon cancer prior to chemotherapy, demonstrating the ability of the Guardant Reveal test to stratify the risk of disease recurrence and overall survival, and thus inform treatment decisions after surgery. Data from the phase III trial of FOLFOX-based adjuvant chemotherapy involving over 2,000 patients with stage III colon cancer with median follow-up of 6.1 years were presented at the 2025 American Society for Clinical Oncology Annual Meeting. Results demonstrated that circulating tumor DNA detected in the bloodstream after cancer surgery and prior to the start of adjuvant therapy, using the Guardant Reveal test, is a strong predictor of the risk of disease recurrence and poorer survival, and suggest the potential for ctDNA testing to improve decision-making at a critical time point for post-operative chemotherapy. Specifically: Among patients with post-surgical ctDNA detected, 62.6% had the cancer return within 3 years, despite having had adjuvant chemotherapy, while only 15.4% of patients with undetectable ctDNA recurred in the same period. The level of ctDNA, or tumor fraction, showed promise in identifying individuals who are less likely to clear residual disease with adjuvant treatment.

‘Absolute Disaster:' Senate Dems Take Aim At Trump's Tax Bill
‘Absolute Disaster:' Senate Dems Take Aim At Trump's Tax Bill

Yahoo

time8 hours ago

  • Yahoo

‘Absolute Disaster:' Senate Dems Take Aim At Trump's Tax Bill

Senate Democrats laid into President Donald Trump's sweeping tax bill on Sunday, emphasizing the impact it is poised to make on millions of Americans on Medicaid. 'This Republican budget bill is an absolute disaster for the country, in particular for middle-class and poor people,' Sen. Chris Murphy (D-CT) said in an interview on CNN's State of the Union, noting that it seeks to pay for tax cuts by curbing spending on social programs. Sen. Raphael Warnock (D-GA) echoed these concerns in an interview on NBC News's Meet the Press, stressing that 'Republicans are trying to push forward this big ugly bill that's going to literally cut as many as seven million Americans off of their healthcare.' Murphy and Warnock's statements come as Republicans' massive tax and spending bill heads to the Senate, where it's likely to face staunch Democratic opposition as well as GOP dissent. The bill slashes spending on social programs like SNAP and Medicaid, while proposing trillions in tax cuts and billions in investments to strengthen border security. According to an initial analysis from the nonpartisan Congressional Budget Office, it would push 7.6 million people off Medicaid, in part by making it more difficult to qualify for the program. One way it does so is by imposing a new work requirement, which would force many able-bodied recipients to prove that they've worked, volunteered or attended a training program to obtain Medicaid coverage. Warnock stressed that a similar policy in Georgia has added new barriers for people in need of healthcare. This 'work reporting requirement is very good at kicking people off of their health care,' he said. 'It's not very good at incentivizing work at all.' Earlier this May, House Republicans narrowly passed the bill by just one vote. It'll take a simple majority – which Republicans have – to advance again in the Senate, though some GOP lawmakers have said they'd like to make changes of their own to tax and Medicaid provisions. GOP Senators like Rick Scott (R-FL) have also raised concerns about how the bill could add to the federal debt, an issue Murphy alluded to as well on Sunday. 'It's just unreal the amount of gaslighting this administration is doing,' Murphy said, while referring to the White House's claims that the legislation won't alter the deficit at all.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store